EN DE
STOCK COMPARISON

WuXi XDC Cayman vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how WuXi XDC Cayman (2268) and Thermo Fisher Scientific (TMO) compare, as of Aug 14, 2026.

As of Aug 14, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: WuXi XDC Cayman trades at HK$63.35 versus a fair value of HK$19.46 (-69%), while Thermo Fisher Scientific trades at $596 versus $308 (-48%).
WuXi XDC Cayman
2268.HK · HKD · Materials
-69%
upside to fair value
overvalued
PriceHK$63.35
Fair ValueHK$19.46
Quality52/100
Thermo Fisher Scientific
TMO · USD · Health Care
-48%
upside to fair value
overvalued
Price$596
Fair Value$308
Quality63/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

WuXi XDC CaymanThermo Fisher Scientific
Valuation
45.6×P/E (TTM)29.5×
12.47×P/S (TTM)4.41×
6.91×P/B3.74×
41.1×EV/EBITDA20.0×
PEG1.74×
Dividend yield0.3%
Dividend per share$1.76
Profitability
25%Net margin15%
26%Operating margin18%
17%Return on equity14%
9%Return on assets5%
Growth
36%Revenue growth (YoY)6%
81.7%Avg. growth/yr (3Y)-0.3%
Avg. growth/yr (5Y)6.7%
Balance & size
0.00×Debt / equity0.67×
$9BMarket cap$199B
mixedGrowth qualityhealthy

WuXi XDC Cayman leads: 7 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

WuXi XDC Caymanof which business quality 53 · market factors 51 Thermo Fisher Scientificof which business quality 60 · market factors 68
ProfitabilityMargins and returns on capital today
54
43
Quality GrowthAre margins and returns improving?
57
31
CashflowEarnings quality: real cash, not paper profit
51
62
Fin. StrengthBalance sheet, leverage, solvency risk
86
60
InvestmentDisciplined investing over empire-building
0
79
Low VolatilityCalm price path (market factor)
56
69
MomentumPrice trend over the last 3–12 months (market factor)
51
65
52W MomentumDistance to the 52-week high (market factor)
47
71
Net IssuanceBuybacks instead of dilution
46
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

WuXi XDC Cayman

DCF ModelsHK$18.00
Earnings-BasedHK$41.11
Dividend DiscountHK$1.52
MultiplesHK$17.24
Asset-BasedHK$5.70
Growth DCFHK$15.30
Economic ProfitHK$15.85
Growth EarningsHK$50.58

26 of 26 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$354
Earnings-Based$203
Multiples$308
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$341

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

WuXi XDC Cayman
Bear HK$12.34Fair Value HK$19.46Bull HK$32.36
HK$63.35 = current price (white tick)
Thermo Fisher Scientific
Bear $171Fair Value $308Bull $385
$596 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

WuXi XDC Cayman · Materials

Quality score52 · above median
Fair value upside-69% · bottom 25%

Thermo Fisher Scientific · Health Care

Quality score63 · Top 25%
Fair value upside-48% · below median

Bottom line

As of Aug 14, 2026, Fair Value Calculator sees Thermo Fisher Scientific as the less overvalued of the two: WuXi XDC Cayman trades at HK$63.35 versus a fair value of HK$19.46 (-69%), while Thermo Fisher Scientific trades at $596 versus $308 (-48%).

Thermo Fisher Scientific has the higher quality score (63/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.